BILAXTEN gtt opht 6 mg/ml fl 5 ml
7680686570016
CH-68657
S01GX13
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
6.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
A. Menarini GmbH
8050 Zürich
Authorization information
- Swissmedic authorization number
- 68657
- Drug name
- BILAXIN Ophta, Augentropfen, Lösung
- Galenic form
- AUL
- ATC Code
- S01GX13
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 09/12/2022
- Authorization expiration date
- 08/12/2027
- IT number
- 11.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BILAXTEN gtt opht 6 mg/ml fl 5 ml
- Description (DE)
- BILAXTEN Gtt Opht 6 mg/ml Fl 5 ml
- Market launch
- 09/12/2022
- Narcotic (BTM)
- No